Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Meropenem Administration in the ICU
NCT05578586Recruiting
- Sponsor
- Oslo University Hospital
- Start
- Dec 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of meropenem in Infection (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Concentration above the minimum inhibitory concentration (MIC) >= 50 % of the time (2 mg/l) at 72 hours. Started Dec 2021; status: recruiting.
02
Drugs
meropenem
03
Conditions
Infection
Beyond the preview
Go deeper on NCT05578586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05578586.